logo


Verenex announces termination of CNPCI Agreement and update on sale process
Tuesday, September 08, 2009 8:19 AM


CALGARY, Sept. 8 /CNW/ - Verenex Energy Inc. ("Verenex" or the "Company") (VNX - TSX) announces that on September 7, 2009, CNPC International Ltd. ("CNPCI") delivered written notice to Verenex terminating the acquisition agreement entered into with Verenex on February 24, 2009 (the CNPCI Agreement").

Under the CNPCI Agreement, CNPCI agreed to make an offer to purchase all of the outstanding Verenex Shares, on a fully-diluted basis, at a price of Cdn$10 per share and to also fund a Cdn$47 million approval bonus to the Libyan National Oil Corporation (the "NOC"). Consent by the NOC to the offer by CNPCI was required under the Exploration and Production Sharing Agreement for Area 47 (the "EPSA"); however, under the terms of the EPSA, such consent cannot be unreasonably withheld.

Despite Verenex having complied with all the requirements of the EPSA and the NOC throughout the public sale process, the NOC has failed or refused to provide consent to the CNPCI Agreement and stated its intent to purchase Verenex subject to approval of the General People's Committee ("GPC").

At this time, Verenex is in discussions with Libyan authorities, including representatives of the GPC, to reach an agreement on the sale of Verenex to a Libyan investment fund on acceptable terms without Verenex having to pursue its legal remedies. The GPC has made it clear to Verenex that it is seeking to negotiate a reduced purchase price.

Investors are cautioned that there can be no assurance that a sale transaction will be concluded.

Forward-Looking Information and Statements

This press release contains forward-looking statements respecting possible actions by the Company. These statements are based on current expectations and are subject to a number of risks and uncertainties that could materially affect the results. These risks include, but are not limited to: risks associated with obtaining regulatory approvals; the uncertainty associated with negotiating with governments; the risks and uncertainties associated with Verenex seeking legal remedies available under the EPSA contract such as arbitration, and the risks associated with international activity. Due to the risks, uncertainties and assumptions inherent in forward-looking statements, prospective investors in the Company's securities should not place undue reliance on these forward-looking statements.

%SEDAR: 00020996E

(Source: CNW )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia